Reduced expression of circulating microRNA-218 in gastric cancer and correlation with tumor invasion and prognosis

World Journal of Gastroenterology

Volumn 20, Issue 22, 2014, Pages 6906-6911

  Xin, Shi Yong ^a   Feng, Xiao Shan ^a   Zhou, Li Qing ^a   Sun, Jun Jun ^a   Gao, Xiao Le ^a   Yao, Guo Liang ^a  

^a HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gastric cancer; Invasion; microRNA 218; Prognosis

Indexed keywords

MICRORNA; MICRORNA 218; UNCLASSIFIED DRUG; MIRN218 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIDDLE AGED; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RNA ISOLATION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR INVASION; VERY ELDERLY; BLOOD; CASE CONTROL STUDY; CELL DIFFERENTIATION; DOWN REGULATION; GENETICS; KAPLAN MEIER METHOD; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; STOMACH TUMOR; TIME;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; DOWN-REGULATION; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 84902126749     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i22.6906     Document Type: Article

References (27)

1. Schistosomes, liver flukes and Helicobacter pylori. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Lyon, 7-14 June 1994. IARC Monogr Eval Carcinog Risks Hum 1994; 61: 1-241 [PMID: 7715068]
2. Davis-Dusenbery BN, Hata A. MicroRNA in Cancer: The Involvement of Aberrant MicroRNA Biogenesis Regulatory Pathways. Genes Cancer 2010; 1: 1100-1114 [PMID: 21533017 DOI: 10.1177/1947601910396213]
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297 [PMID: 14744438 DOI: 10.1016/S0092-8674(04)00045-5]
4. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355 [PMID: 15372042 DOI: 10.1038/nature02871]
5. Bushati N, Cohen SM. microRNA functions. Annu Rev Cell Dev Biol 2007; 23: 175-205 [PMID: 17506695 DOI: 10.1146/ annurev.cellbio.23.090506.123406]
6. Yekta S, Shih IH, Bartel DP. MicroRNA-directed cleavage of HOXB8 mRNA. Science 2004; 304: 594-596 [PMID: 15105502 DOI: 10.1126/science.1097434]
7. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531 [PMID: 15211354 DOI: 10.1038/nrg1379]
8. Ambros V. microRNAs: tiny regulators with great potential. Cell 2001; 107: 823-826 [PMID: 11779458 DOI: 10.1016/ S0092-8674(01)00616-X]
9. Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell 2006; 11: 441-450 [PMID: 17011485 DOI: 10.1016/j.devcel.2006.09.009]
10. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR, Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838 [PMID: 15944708 DOI: 10.1038/nature03702]
11. Miska EA. How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev 2005; 15: 563-568 [PMID: 16099643 DOI: 10.1016/j.gde.2005.08.005]
12. Esquela-Kerscher A, Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269 [PMID: 16557279 DOI: 10.1038/nrc1840]
13. Uesugi A, Kozaki K, Tsuruta T, Furuta M, Morita K, Imoto I, Omura K, Inazawa J. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer. Cancer Res 2011; 71: 5765-5778 [PMID: 21795477 DOI: 10.1158/0008-5472. CAN-11-0368]
14. Zhang B, Pan X, Cobb GP, Anderson TA. microRNAs as oncogenes and tumor suppressors. Dev Biol 2007; 302: 1-12 [PMID: 16989803 DOI: 10.1016/j.ydbio.2006.08.028]
15. Tatarano S, Chiyomaru T, Kawakami K, Enokida H, Yoshino H, Hidaka H, Yamasaki T, Kawahara K, Nishiyama K, Seki N, Nakagawa M. miR-218 on the genomic loss region of chromosome 4p15.31 functions as a tumor suppressor in bladder cancer. Int J Oncol 2011; 39: 13-21 [PMID: 21519788 DOI: 10.3892/ijo.2011.1012]
16. Wu DW, Cheng YW, Wang J, Chen CY, Lee H. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 2010; 70: 10392-10401 [PMID: 21159652 DOI: 10.1158/0008-5472.CAN-10-2341]
17. Song L, Huang Q, Chen K, Liu L, Lin C, Dai T, Yu C, Wu Z, Li J. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun 2010; 402: 135-140 [PMID: 20933503 DOI: 10.1016/ j.bbrc.2010.10.003]
18. Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, Bruce J, Yue S, Huang SH, Xu W, Waldron J, O'Sullivan B, Liu FF. MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 2011; 71: 2381-2391 [PMID: 21385904 DOI: 10.1158/0008-5472.CAN-10-2754]
19. Tie J, Pan Y, Zhao L, Wu K, Liu J, Sun S, Guo X, Wang B, Gang Y, Zhang Y, Li Q, Qiao T, Zhao Q, Nie Y, Fan D. MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 2010; 6: e1000879 [PMID: 20300657 DOI: 10.1371/journal.pgen.1000879]
20. Gao C, Zhang Z, Liu W, Xiao S, Gu W, Lu H. Reduced microRNA-218 expression is associated with high nuclear factor kappa B activation in gastric cancer. Cancer 2010; 116: 41-49 [PMID: 19890957 DOI: 10.1002/cncr.24743]
21. Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, Croce CM, Vecchione A. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008; 13: 272-286 [PMID: 18328430 DOI: 10.1016/j.ccr.2008.02.013]
22. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC, Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 2006; 103: 2257-2261 [PMID: 16461460 DOI: 10.1073/pnas.0510565103]
23. Zanette DL, Rivadavia F, Molfetta GA, Barbuzano FG, Proto-Siqueira R, Silva-Jr WA, Falcão RP, Zago MA. miRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemia. Braz J Med Biol Res 2007; 40: 1435-1440 [PMID: 17934639 DOI: 10.1590/S0100-879X2006005000179]
24. Hermeking H. p53 enters the microRNA world. Cancer Cell 2007; 12: 414-418 [PMID: 17996645 DOI: 10.1016/j.ccr.2007.10.028]
25. Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol 2010; 116: 140-146 [PMID: 19880165 DOI: 10.1016/j.ygyno.2009.09.040]
26. Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN. MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res 2010; 107: 1336-1344 [PMID: 20947829 DOI: 10.1161/CIRCRESAHA.110.227926]
27. Li W, Li H, Li J, Wang H, Zhao H, Zhang L, Xia Y, Ye Z, Gao J, Dai J, Wang H, Guo Y. Self-assembled supramolecular nano vesicles for safe and highly efficient gene delivery to solid tumors. Int J Nanomedicine 2012; 7: 4661-4677 [PMID: 22977303 DOI: 10.2147/IJN.S34675]